Bullish
Johnson & Johnson proposes $5.5 billion talc settlement, stock rises over 2%.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve ongoing lawsuits alleging its talc products caused ovarian cancer. This move aims to conclude over a decade of litigation and has positively impacted the company's stock, which rose more than 2% before the market opened.
Key points
- Proposed $5.5 billion settlement to resolve talc-related lawsuits.
- Stock price increased by over 2% following the settlement announcement.
- Settlement contingent on at least 95% claimant participation.
- Initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Sources
- Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fightAssociated Press · July 28, 2026
- Johnson & Johnson pagará casi 5.000 millones en EE UU para zanjar las demandas del talco como causa de cáncerEl País · July 28, 2026
- Johnson & Johnson pagará cerca de 5.000 millones de euros para zanjar las demandas que vinculan su talco con el cáncerCadena SER · July 28, 2026
AI-generated from public news sources. Not financial advice.
